WuXi AppTec, the Shanghai-based biotech giant, has sold its South Philly-based WuXi Advanced Therapies contract manufacturing ...
WuXi Biologics Cayman Inc. will sell a vaccine facility in Ireland to Merck & Co. for about $500 million as the Chinese ...
China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...
China's WuXi Biologics said on Monday it will sell its vaccine facility in Ireland to U.S. drugmaker Merck & Co for about ...
Candid Therapeutics is continuing its mission to flesh out a pipeline of T-cell engagers in record time, signing a ...
GlobalData on MSN2d
WuXi Biologics to sell Ireland-based vaccine site to MSD for $500mThe transaction is expected to close in the first half of 2025, subject to the satisfaction of customary closing conditions.
Wuxi Biologics (WXXWY) plans to sell its Irish vaccine facility to Merck (MRK) for around $500M ahead of potential U.S. legislation that would ...
In Ireland, WuXi Biologics has sold a new vaccines plant to Merck & Co. for €500 million ($521 million). The New Jersey ...
US pharmaceutical group adds eighth Irish manufacturing site to its network as it promises to deliver 1,000 jobs this year ...
JPMorgan upgraded Wuxi Biologics (WXXWY) to Overweight from Neutral with a price target of HK$20, up from HK$13, citing expected order growth ...
02/01/2025 14:07 {Hot Stocks}4 listed firms see price swing at 2:06pm 02/01/2025 09:50 {Hot Stocks}2 listed firms see price swing at 9:49am 30/12/2024 13:50 {Hot Stocks}4 listed firms see price swing ...
WuXi Biologics, a Chinese biopharmaceuticals company, announced on Monday the sale of its WuXi Vaccines facility in Ireland ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback